NuvoResearch.com NuvoResearch.com
Mailing ListMailing ListContactsContactsStock QuoteStock QuoteSite MapSite Map
Transdermal Delivery
Immune Regulation
Home
Company Company
History & Milestones
Executive Team
Subsidiaries
Distribution Partners
Pipeline Pipeline
Transdermal Drug Delivery
Immune Regulation
Technology Technology
MMPE
HTE
Investors Investors
News Releases
Financial Reports
Webcasts and Presentations
Corporate Governance
Shareholder Information
Info Request
Publications Publications
Transdermal Delivery
Immune Regulation
Technology
Careers Careers

News Releases


News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.

Year: 2010 : 2009 : 2008 : 2007


November 25, 2008 Nuvo Research Subsidiary Signs Collaboration Agreement With Fortune Global 500 Company 
October 30, 2008 Nuvo Announces Third Quarter 2008 Financial Results
October 27, 2008 Nuvo Research Presents Positive Phase III Study Results for Pennsaid at Leading Rheumatology Conference
September 18, 2008 Nuvo Announces Debenture Holders Agree to Resolution
August 1, 2008 Nuvo Announces Proposed Amendments to Outstanding Convertible Debentures
July 31, 2008 Nuvo Announces Second Quarter 2008 Financial Results
July 8, 2008 Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
June 3, 2008 New Improved Dosing Approved for Pennsaid
May 29, 2008 Nuvo Licenses Topical Pain Product From Paladin
May 1, 2008 Nuvo Announces First Quarter 2008 Financial Results
February 21, 2008 Nuvo Announces 2007 Fourth Quarter and Year End Financial Results

All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.

Back to top